Search results for "Pulmonary embolism"
Extended anticoagulant treatment prevents recurrent VTE after first unprovoked PE
An additional 18 months of warfarin treatment in patients with first unprovoked PE improves outcomes versus placebo, although the improvement was not sustained after anticoagulant treatment was discontinued.
https://immattersacp.org/weekly/archives/2015/07/14/2.htm
14 Jul 2015
Age-adjusted D-dimer cutoff appears better at ruling out PE
D-dimer cutoffs adjusted for age performed better than a fixed D-dimer cutoff for safely ruling out pulmonary embolism (PE), especially in elderly patients, according to a new study.
https://immattersacp.org/weekly/archives/2014/03/25/6.htm
25 Mar 2014
Fixed-dose oral rivaroxaban appears noninferior to standard therapy for PE
Fixed-dose oral rivaroxaban is as effective as standard anticoagulant therapy for pulmonary embolism (PE) and may have a lower bleeding risk, a new study found.
https://immattersacp.org/weekly/archives/2012/03/27/5.htm
27 Mar 2012
Wells and Geneva scores evaluated for risk stratification for PE in primary care
Discriminative ability was comparable for the original Wells, modified Wells, simplified Wells, revised Geneva, and simplified revised Geneva models, but the Wells rules had lower failure rates.
https://immattersacp.org/weekly/archives/2015/09/15/1.htm
15 Sep 2015
MKSAP Quiz: deep venous thrombosis following surgery
A 28-year-old man is evaluated 24 hours after a new diagnosis of a left calf deep venous thrombosis. One week ago, he underwent orthopedic surgery. Two weeks ago, he returned from vacationing in Italy on an 8-hour flight. Current medications are enoxaparin, 80 mg subcutaneously twice daily, and warfarin, 5 mg/d. What is the most appropriate management of this patient's venous thromboembolism?
https://immattersacp.org/weekly/archives/2013/02/05/3.htm
5 Feb 2013
MKSAP Quiz: 4-month history of progressive dyspnea, fatigue
A 61-year-old woman is evaluated for a 4-month history of progressive dyspnea and fatigue without chest pain. Eighteen months ago, she was diagnosed with liver cirrhosis due to nonalcoholic steatohepatitis (NASH). Medical history is also significant for obesity. Medications are propranolol, spironolactone, and lactulose. Following a physical exam, lab tests, and scans, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2016/03/22/3.htm
22 Mar 2016
Expanded approval on rivaroxaban, reassurance on dabigatran
This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013
Patients with SVT may also have DVT
Proposed updates for DSM-5 released
https://immattersacp.org/weekly/archives/2010/02/16/5.htm
16 Feb 2010
Aspirin appears to reduce recurrence of VTE after stopping anticoagulants
Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study found.
https://immattersacp.org/weekly/archives/2012/06/05/6.htm
5 Jun 2012
Pros, cons of prolonged anticoagulation after a clot
Experts debate about provoked vs. unprovoked venous thromboembolism, and whether a once-high-risk patient can have that status removed later.
https://immattersacp.org/archives/2020/02/pros-cons-of-prolonged-anticoagulation-after-a-clot.htm
1 Feb 2020